• 1. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 2. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 3. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734
• 4. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 5. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082

Professional Introduction to Compound with CAS No. 702-08-9 and Product Name: 1-fluoro-4-(2-methylprop-2-enyl)benzene

The compound with CAS No. 702-08-9 and the product name 1-fluoro-4-(2-methylprop-2-enyl)benzene represents a significant area of interest in the field of pharmaceutical chemistry and organic synthesis. This aromatic compound, featuring a fluoro substituent and an isopropenyl group, has garnered attention due to its unique structural properties and potential applications in medicinal chemistry. The presence of a fluorine atom at the para position relative to the isopropenyl group introduces a degree of electronic and steric modulation that can influence its reactivity and biological activity.

In recent years, the pharmaceutical industry has increasingly recognized the value of fluorinated aromatic compounds in drug development. The introduction of fluorine atoms into molecular structures can enhance metabolic stability, improve binding affinity to biological targets, and modulate pharmacokinetic profiles. The compound 1-fluoro-4-(2-methylprop-2-enyl)benzene exemplifies this trend, as its structural features make it a promising candidate for further exploration in medicinal chemistry.

One of the most compelling aspects of this compound is its potential as a building block for more complex drug molecules. The combination of a fluoro group and an isopropenyl moiety provides a versatile scaffold that can be modified through various chemical reactions, such as cross-coupling reactions, nucleophilic substitutions, and functional group interconversions. These modifications allow chemists to tailor the compound's properties for specific applications, including the development of novel therapeutic agents.

Recent studies have highlighted the importance of 1-fluoro-4-(2-methylprop-2-enyl)benzene in the synthesis of bioactive molecules. For instance, researchers have utilized this compound as an intermediate in the preparation of fluorinated heterocycles, which are known for their enhanced bioavailability and reduced susceptibility to degradation by metabolic enzymes. The isopropenyl group also offers opportunities for further functionalization, enabling the creation of diverse chemical libraries for high-throughput screening.

The pharmacological potential of this compound has been explored in several contexts. Initial studies have suggested that derivatives of 1-fluoro-4-(2-methylprop-2-enyl)benzene may exhibit properties relevant to neurological disorders, inflammation, and cancer treatment. The fluoro substituent's ability to influence electronic distribution has been particularly noted in designing molecules with improved receptor binding affinity. Additionally, the compound's lipophilicity, influenced by both the fluoro group and the isopropenyl moiety, makes it a candidate for oral administration and systemic delivery.

In synthetic chemistry, 1-fluoro-4-(2-methylprop-2-enyl)benzene has been employed in various methodologies that leverage its unique reactivity. For example, palladium-catalyzed cross-coupling reactions have been used to introduce additional aryl or vinyl groups at different positions on the benzene ring. These reactions are highly regioselective and provide access to a wide range of substituted derivatives with tailored properties. Furthermore, the compound's stability under various reaction conditions makes it suitable for large-scale synthesis, which is crucial for industrial applications.

The role of computational chemistry in optimizing derivatives of 1-fluoro-4-(2-methylprop-2-enyl)benzene cannot be overstated. Molecular modeling techniques have been instrumental in predicting the biological activity and pharmacokinetic behavior of potential drug candidates before experimental synthesis. By simulating interactions with biological targets such as enzymes and receptors, researchers can identify structural modifications that enhance efficacy while minimizing side effects. This approach accelerates the drug discovery process by reducing the number of compounds that require experimental validation.

Future directions in the study of 1-fluoro-4-(2-methylprop-2-enyl)benzene may include exploring its role in developing next-generation therapeutics. The integration of machine learning algorithms into drug discovery pipelines has opened new possibilities for identifying novel molecular structures with desired properties. By combining experimental data with predictive models, researchers can design more sophisticated derivatives that address unmet medical needs more effectively.

In conclusion, 1-fluoro-4-(2-methylprop-2-enyl)benzene represents a valuable asset in pharmaceutical research due to its structural versatility and potential biological activity. Its unique combination of functional groups makes it an attractive scaffold for developing innovative therapeutic agents across multiple disease areas. As research continues to advance our understanding of fluorinated aromatic compounds, compounds like this will undoubtedly play a pivotal role in shaping the future of medicine.

• 2248-13-7(4-(4-Fluorophenyl)-1-butene)
• 222640-88-2(Benzene,1-(2E)-2-buten-1-yl-4-fluoro-)
• 326879-12-3(Benzene,1-fluoro-4-(1-methylenepropyl)-)
• 731772-97-7(Benzene,1-fluoro-2-(2-methyl-2-propen-1-yl)-)
• 30984-53-3(1-fluoro-3-prop-2-en-1-ylbenzene)
• 701-80-4(1-fluoro-3-(2-methylprop-2-en-1-yl)benzene)
• 869493-79-8(1-fluoro-2-methyl-4-(2-methylprop-2-enyl)benzene)
• 1737-16-2( )
• 731773-07-2(Benzene,1-fluoro-3-(3-methyl-3-buten-1-yl)-)
• 731773-12-9(4-(4-Fluorophenyl)-2-methyl-1-butene)